Domingo Andrés PASCUAL FIGAL

McEwan P, Harrison C, Binnie R, Lewis RD, Cohen-Solal A, Lund LH, Ohlsson M, von Haehling S, Comin-Colet J, Pascual-Figal DA, Wachter S, Dorigotti F, de Arellano AR, Ponikowski P, Jankowska EA. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalisation: A European multinational economic evaluation. Eur J Heart Fail. 2023 Jan 31. doi: 10.1002/ejhf.2788. Online ahead of print. PubMed PMID: 36718652.

AÑO: 2023; IF: 18.2

36718652

Diez-Diez M, Amoros-Perez M, de la Barrera J, Vazquez E, Quintas A, Pascual-Figal DA, Dopazo A, Sanchez-Cabo F, Kleinman ME, Gordon LB, Fuster V, Andres V, Fuster JJ. Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. Geroscience. 2023 Apr;45(2):1231-1236. doi: 10.1007/s11357-022-00607-2. Epub 2022 Jun 25. PubMed PMID: 35752705; PubMed Central PMCID: PMC9886702.

AÑO: 2023; IF: 5.6

35752705

Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. PubMed PMID: 34861154.

AÑO: 2022; IF: 44.5

34861154

Chalkias A, Skoulakis A, Papagiannakis N, Laou E, Tourlakopoulos K, Pagonis A, Michou A, Ntalarizou N, Mermiri M, Ragias D, Bernal-Morell E, Cebreiros Lopez I, Garcia de Guadiana-Romualdo L, Eugen-Olsen J, Gourgoulianis K, Pantazopoulos I; SPARCOL Investigators. Circulating suPAR associates with severity and in-hospital progression of COVID-19. Eur J Clin Invest. 2022 Jul;52(7):e13794. doi: 10.1111/eci.13794. Epub 2022 May 4. PubMed PMID: 35435245; PubMed Central PMCID: PMC9111634.

AÑO: 2022; IF: 5.5

35435245

Haroon MZ, Farooq U, Ashraf S, Zeb S, Gillani SY, Malik S, Ali R, Irshad R, Mehmood Z, Abbas Y, Masood A, Ghafoor A, Khalil AT, Asif H, Khan S, Ujjan ID, Nigar R, Livingstone S, Pascual-Figal DA, Togni S, Allergini P, Riva A, Khan A. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial. J Physiol Pharmacol. 2022 Jun;73(3). doi: 10.26402/jpp.2022.3.09. Epub 2022 Oct 22. PubMed PMID: 36302537.

AÑO: 2022; IF: 2.2

36302537